SecureKloud Technologies discloses voting results of 41st AGM
- All four resolutions at SecureKloud's 41st AGM passed with requisite majority
- Healthcare Triangle deal ratification approved despite promoter abstention
- FY26 financial statements adopted; Vijaykumar Mayakesavan re-appointed as Director
- Material related party transactions for FY27 approved by public shareholders

*this image is generated using AI for illustrative purposes only.
SecureKloud Technologies Limited has disclosed the voting results of its 41st Annual General Meeting (AGM) held on September 25, 2026. All four resolutions proposed at the meeting were passed with the requisite majority, including the ratification of key strategic agreements involving Healthcare Triangle Inc., USA.
The meeting, conducted via Video Conferencing, focused on adopting financial statements for FY26 and approving material related party transactions. The disclosure was made pursuant to Regulation 44(3) of the SEBI (LODR) Regulations and Section 108 of the Companies Act, 2013.
Voting Results Summary
The following table outlines the outcome of the four resolutions considered by shareholders:
| Resolution | Type | Promoter Interest | Result |
|---|---|---|---|
| Adoption of FY26 Financial Statements | Ordinary | No | Passed |
| Re-appointment of Vijaykumar Mayakesavan | Ordinary | No | Passed |
| Ratification of Securities Exchange Agreement | Ordinary | Yes | Passed |
| Approval of Material RPT for FY27 | Ordinary | Yes | Passed |
For Resolutions 3 and 4, which involved related party transactions with Healthcare Triangle entities, the promoter group abstained from voting as they are interested in the agenda. The public shareholders voted in favor of these resolutions with a significant majority.
Key Resolutions Passed
Shareholders approved the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Mr. Vijaykumar Mayakesavan was re-appointed as a Director in place of himself, having retired by rotation.
Two special business items were central to the proceedings:
- Ratification of the Securities Exchange Agreement entered into by the Company with Healthcare Triangle Inc., USA.
- Approval of material related party transactions between Healthcare Triangle Private Limited and Healthcare Triangle Inc., USA for the financial year 2026-27.
Meeting Proceedings and Attendance
The meeting commenced at 10:00 am IST with a quorum of 43 shareholders present. Chairman Suresh Venkatachari briefed members on future prospects in AI-related businesses. No members exercised the option to speak or raise queries during the session.
The following table outlines the attendance of key personnel:
| Person | Designation | Mode of Attendance |
|---|---|---|
| Suresh Venkatachari | Chairman & CEO | VC (Kuala Lumpur) |
| Venkateswaran Krishnamurthy | Whole-time Director & CRO | Leave of Absence |
| Vijaykumar Mayakesavan | Non-executive Director | VC (Chennai) |
| Venkatesh Rajaratnam | Independent Director | VC (Chennai) |
| Jayanthi Talluri | Independent Director | VC (Hyderabad) |
| Duraiswamy Basuvaiah | Independent Director | Leave of Absence |
| A.V.N Srimathi | Independent Director | Leave of Absence |
E-Voting and Conclusion
Remote e-voting facilities were provided by CDSL for shareholders who had not voted prior to the meeting. The e-voting window remained open for 15 minutes after the conclusion of the discussion. The results, based on the report of Scrutinizer Jayanth Viswanathan, have been disseminated to stock exchanges.
The meeting concluded at 10:33 am IST with a vote of thanks to the chair.
Historical Stock Returns for SecureKloud Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.45% | -0.23% | -4.62% | -19.69% | -27.90% | -90.95% |
How will the ratified Securities Exchange Agreement with Healthcare Triangle Inc. impact SecureKloud's balance sheet and shareholding structure in the coming quarters?
What specific AI-related business initiatives did Chairman Suresh Venkatachari highlight as key drivers for future growth, and what is the expected timeline for their revenue contribution?
Given the significant public shareholder support for related party transactions despite promoter abstention, how might this influence future governance perceptions and investor confidence?


































